The Biomimetic Innovations team were thrilled to join Sanara Medtech in Dallas, TX last week for their first dedicated training session on OsSticĀ®.
In January this year BMI entered into an exclusive U.S. license and distribution agreement (Trauma) and made a minority investment in Sanara MedTech (Nasdaq: SMTI).
This training event represents a key milestone on the path to bringing OsSticĀ® into clinical use for patients across the U.S.
Weāre excited to collaborate with Sanara MedTech in pursuit of our shared mission: to enhance patient wellbeing.
#OsStic #bioadhesive #acceleratingmedicalinnovation #pbcbiomed #sanaramedtech #partnership
